Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT05934266
Active, not recruiting Phase 4

Impact of Mesh Fixation With Tissue Adhesive

NCT05934266 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital Universitario de Móstoles
Phase
Phase 4
Started
2023-03-29
Last updated
2025-05-02

Condition(s) studied

Groin HerniaHernia, InguinalPostoperative PainNeuropathic Pain

Investigational drug(s) / intervention(s)

Use of n-hexyl cyanoacrylate for mesh fixation

Use of n-hexyl cyanoacrylate for mesh fixation: Mesh fixation with tissue adhesive (n-hexyl cyanoacrylate) in open hernia repair

Study summary

Randomized controlled trial on mesh fixation using cyanoacrylate glue compared to standard suture in open inguinal hernia repair.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Elective open inguinal hernioplasty in patients over 18 years old Exclusion Criteria: * Patient refusal * Laparoscopic surgery * Reintervention surgery * Urgent surgery * Cyanoacrylate allergy * Administration of intraoperative local anesthetics * Comorbidities that may affect the requirements of analgesics, such as degenerative arthropathies, fibromyalgia, etc.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario de Móstoles Móstoles Madrid

Other trials for the same condition

PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery. Recruiting
Serratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy Active, not recruiting
Modulation of the Inflammatory Response in Bariatric Surgery Recruiting
Factors Influencing Postoperative Pain After Gingival Graft Harvesting Recruiting
Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05934266 on ClinicalTrials.gov ↗ ← All trials in Spain